-
BGM0504 Injection GLP-1/GIP Receptor AgonistProduct Name: BGM0504 Injection GLP-1/GIP receptor agonist Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinicalread more
-
Incretin Analogs BGM0504Product Name: Incretin Analogs BGM0504 Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more
-
Dual GLP-1/GIP Receptor Agonist BGM0504Product Name: Dual GLP-1/GIP receptor agonist BGM0504 Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinicalread more
-
Semaglutide Oral Tablets 7mgProduct Name: Semaglutide Oral Tablet 7mg Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more
-
Semaglutide Weight Loss TabletsProduct Name: Semaglutide weight loss tablets Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progressread more
-
Semaglutide TabletsProduct Name: Semaglutide tablets Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more
-
Argatroban InjectionProduct Name: Argatroban Injection Cas. 74863-84-6 Molecular Formula C23H36N6O5S Molecular Weight 508.63 Appearance White to off-white powderread more
-
Eribulin Mesylate InjectionProduct Name: Eribulin Mesylate Injection Cas. 441045-17-6 Molecular Formula C41H63NO14S Molecular Weight 826.01 Appearance Colorless liquidread more
-
Oseltamivir Phosphate Suspension and CapsuleProduct Name: Oseltamivir Phosphate Suspension and Capsule Cas. 204255-11-8 Molecular Formula C16H31N2O8P Molecular Weight 410.4 Appearance White to off-white powder Storage Sealed,read more
-
Tiotropium Bromide and Olodaterol Hydrochloride SMIProduct Name: Tiotropium Bromide and Olodaterol Hydrochloride Appearance Colorless liquidread more
-
Octreotide Acetate LAR InjectionProduct Name: Octreotide Acetate LAR Injection Cas. 83150-76-9 Molecular Formula C49H66N10O10S2 Molecular Weight 1019.24 Appearance Colorless liquidread more
-
Leuprorelin Acetate LAR InjectionProduct Name: Leuprorelin Acetate LAR Injection Cas. 74381-53-6 Molecular Formula C61H88N16O14 Molecular Weight 1269.47 Appearance White to off-white powderread more
WEBMay 14, 2024 · Exploring and Managing GLP-1 Receptor Agonists in Weight Loss. Guiding Obesity Management by Understanding Weight Loss Drugs. Glucagon-like...
WEBAug 21, 2024 · Abstract. To the Editor: The distribution framework for glucagon-like peptide-1 (GLP-1) receptor agonists proposed by Emanuel et al. in their Perspective article (May 30 issue) 1...
WEBAug 20, 2024 · Tirzepatide, a GIP and GLP-1 receptor agonist, works by activating the two hormone receptors. GLP-1 is a regulator of appetite and caloric intake. Nonclinical...
WEB1 day ago · Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double...
WEB3 days ago · Mounjaro and Zepbound (tirzepatide) are injectable GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) agonists. Like GLP-1, GIP is a hormone that...
WEBGLP-1 is released in the gut in the presence of glucose and stimulates the release of insulin from pancreatic B cells, enabling fine control of blood sugar levels. The first drug...
